FDA: Oral Contraceptives and Increased Risk for Blood Clots
The U.S. Food and Drug Administration announced Monday a “continued concern” regarding the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. The FDA conducted a study which suggests there is an approximately 1.5-fold increase in the risk of blood clots for women who use drospirenone-containing birth control pills compared to users of other hormonal contraceptives. Some common names of these types of contraceptives include: Yaz, Yasmin, and Ocella.
Bayer Corporation manufactures Yaz, Yasmin, and Ocella and has marketed this product as a safe and effective oral contraceptive. However, studies have shown that drospirenone-containing birth control pills have been linked to an increase in potassium levels in the blood which can cause heart rhythm disturbances that could lead to blood clots and/or stroke, and can be fatal if left untreated. Drospirenone can also cause gall bladder disease and kidney stone formation, which can require surgery.
CohenMalad, LLP currently represents many women across the country who have sustained devastating and life threatening injuries as a result of ingesting Yaz, Yasmin, or Ocella. If you or a loved one has suffered as a result of the use of Yaz, Yasmin, or Ocella, please contact our office today to speak with one of our product liability/personal injury attorneys to discuss your legal options.
